Menu
Back to Journals » OncoTargets and Therapy » Volume 13
RETRACTED ARTICLE: Long Non Coding RNA SNHG16 Facilitates Proliferation, Migration, Invasion and Autophagy of Neuroblastoma Cells via Sponging miR-542-3p and Upregulating ATG5 Expression
Authors Wen Y, Gong X, Dong Y, Tang C
Received 12 August 2019
Accepted for publication 2 December 2019
Published 10 January 2020 Volume 2020:13 Pages 263—275
DOI https://doi.org/10.2147/OTT.S226915
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Sanjay Singh
This paper has been retracted.
Wen Y, Gong X, Dong Y, Tang C. Onco Targets Ther. 2020;13:263—275.
We, the Editor and Publisher of the journal OncoTargets and Therapy, have retracted the following article.
Following publication, concerns were raised regarding Figure(s) 6 and 2d. In 2024, the authors contacted the journal to request withdrawal due to errors in the data.
When asked for further information and an explanation for the image concerns, the authors did not respond. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.